Iceland· IS-EU/1/13/828/001
Hexacima
A diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b product, registered in Iceland by Sanofi Winthrop Industrie. The same ATC class is registered in 10 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b is registered in 10 of 19 countries.
Countries holding a registration under ATC J07CA09 (diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b · ATC J07CA09
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Iceland (IS)
- ATC code
- J07CA09
- ATC class
- Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07CA09
Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b, as other registers publish it.
- IcelandHexacimaSanofi Winthrop Industrie
- DenmarkHexacimaSanofi Winthrop Industrie
- FinlandHexacimaSanofi Winthrop Industrie
- PolandHexacimaSanofi Pasteur
- BelgiumHexacimaSanofi Winthrop Industrie
- FinlandHexacimaSanofi Winthrop Industrie
- BelgiumHexacimaSanofi Winthrop Industrie
- CzechiaHEXACIMASanofi Winthrop Industrie, Gentilly
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bcd63476-3cc2-4238-9efc-aa7b06dfb679 GET /v1/drugs/bcd63476-3cc2-4238-9efc-aa7b06dfb679?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, dreifa",
"source": "lyfjastofnun",
"atc_raw": "J07CA09",
"marketed": false,
"strength": null,
"ma_number": "EU/1/13/828/001",
"substance": "Tetanus toxoid,HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE),Filamentous haemagglutinin,Diphtheria Toxoid,HEPATITIS B SURFACE ANTIGEN,PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED,Poliovirus (inactivated) type 1 (Mahoney strain),Poliovirus (inactivated) type 2 (MEF-1 strain),Poliovirus (inactivated) type 3 (Saukett strain),Tetanus protein",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "41411"
}See everything about diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.